Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000921895-25-000649·Bio Green Med Solution, Inc.
Schedule 13D ownership disclosure
CYCLACEL PHARMACEUTICALS INC
Common Stock, $0.001 par value · CUSIP: 23254L801
Event date: 2025-02-06
- Filing-level shares
- 39,021,180.00
- Percent of class
- 15.84%
- Lazar David E.Reported CIK 0001932843
Shares: 39,021,180.00 · Class: 15.84%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000649
- Form type
- SCHEDULE 13D
- Filer
- Bio Green Med Solution, Inc.
- CIK
- CIK 1130166
- Filed
- Feb 28, 2025
- Reporting period
- Feb 06, 2025
- Description
- Schedule 13D beneficial ownership